Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
About the Role We are looking for a teaching fellow to undertake a one-year post in the school, to support the delivery of our taught postgraduate programme in Engineering Management. About You We
-
the University, in accordance with the Immigration, Asylum and Nationality Act 2006. Full-Time, Permanent Applications are invited for the post of Research Contracts and IP Manager in the Research Contracts team
-
About the Role Applications are sought for a Project Coordinator in Global Child Health Research to manage a portfolio of studies. This is a wide-ranging role which will allow the post-holder
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
to improve people's health in developing countries by striving for excellence in research, healthcare, and training. Our research program spans basic scientific research, clinical studies, epidemiological
-
, the successful post holder will have the ability to follow procedure and process, and plan, manage and prioritise workload when under pressure to meet deadlines. We offer a generous reward package and benefits
-
About the Role To undertake research investigations in collaboration with and under the supervision of Dr Saroash Shahid and Prof Mangala Patel, to deliver the objectives of the research programme
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing